<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/merck-sac-tmt-improves-survival-gastroesophageal-cancer-trial</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-22T08:04:17.308Z</news:publication_date>
      <news:title>Merck Drug Lifts Survival in 473-Patient Trial, Misses Secondary Goal</news:title>
      <news:keywords>Merck, sacituzumab tirumotecan, antibody drug conjugate, gastroesophageal cancer, phase 3</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/merck-drops-nemtabrutinib-blood-cancer-drug-arqule</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T14:02:35.994Z</news:publication_date>
      <news:title>Merck Drops Blood Cancer Drug It Got in $2.7B ArQule Buyout</news:title>
      <news:keywords>Merck, Nemtabrutinib, Leukemia, BTK inhibitor, Clinical trials</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/novartis-shares-fall-after-5-percent-growth-goal-through-2031</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T08:11:36.980Z</news:publication_date>
      <news:title>Novartis Shares Fall 3.3% After It Sets a 5% Yearly Growth Goal</news:title>
      <news:keywords>Novartis, Investor Day, Sales Outlook, Kesimpta, Patent Expiry</news:keywords>
    </news:news>
  </url>
</urlset>